Show simple item record

dc.contributor.authorChipps, Jennifer
dc.contributor.authorDzansi, Gladys
dc.contributor.authorTornu, Eric
dc.date.accessioned2021-01-22T09:37:51Z
dc.date.available2021-01-22T09:37:51Z
dc.date.issued2020
dc.identifier.citationChipps, J. et al. (2020). Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population. PLoS ONE ,15(3),e0230159en_US
dc.identifier.issn1932-6203
dc.identifier.uri10.1371/journal.pone.0230159
dc.identifier.urihttp://hdl.handle.net/10566/5728
dc.description.abstractAdherence to antiretroviral therapy (ART) is essential to achieving an improved cluster of differentiation-4 (CD4) count, viral load, and quality of life while preventing drug resistance. Medication adherence among people living with Human Immunodeficiency Virus (HIV) is influenced by different factors. Several studies have identified adherence promoters and inhibitors that emanate from the internal and external environment. We conducted six (6) individual in-depth interviews and three (3) focus group discussions to explore adherence behaviour among patients diagnosed with HIV in a teaching hospital in Accra, Ghana. Participants were drawn from the intervention arm of a mobile phone adherence intervention program. They had been enrolled in the study for at least six (6) months before the interviews are conducted.en_US
dc.language.isoenen_US
dc.publisherPublic Library of Scienceen_US
dc.subjectHIV/AIDS patientsen_US
dc.subjectAntiretroviral therapyen_US
dc.subjectGhanaen_US
dc.subjectDrug resistanceen_US
dc.subjectTreatment planningen_US
dc.titlePromoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved populationen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record